Savara (SVRA) Non-Current Deferred Tax Liability (2011 - 2018)

Savara's (SVRA) quarterly Non-Current Deferred Tax Liability came in at $2.5 million in Q3 2018, down 77.5% year-on-year from $11.3 million in Q3 2017, and down 0.78% on a QoQ basis from $2.6 million in Q2 2018.

Savara (SVRA) Non-Current Deferred Tax Liability (2011 - 2018) Analysis & Trends

Savara (SVRA) has 8 years of Non-Current Deferred Tax Liability data on file, last reported at $2.5 million in Q3 2018.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 77.5% year-over-year to $2.5 million in Q3 2018; TTM through Sep 2018 was $2.5 million, a 77.5% decrease from a year earlier, with the FY2017 full-year figure at $7.2 million, up 211.54% from the prior year.
  • Non-Current Deferred Tax Liability for Q3 2018 stood at $2.5 million, down from $2.6 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for SVRA reached as high as $11.3 million in Q3 2017 and fell as low as $995000.0 in Q1 2017.
  • Historically, Non-Current Deferred Tax Liability has averaged $4.1 million across 5 years, with a median of $3.4 million in 2014.
  • Across the five-year window, Non-Current Deferred Tax Liability surged 230.88% in 2017 and plunged 77.5% in 2018, its largest moves.
  • Year by year, Non-Current Deferred Tax Liability stood at $3.4 million in 2014, then changed by 0.0% to $3.4 million in 2015, then plunged by 32.29% to $2.3 million in 2016, then surged by 211.54% to $7.2 million in 2017, then slumped by 64.71% to $2.5 million in 2018.
  • Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $2.5 million in Q3 2018, $2.6 million in Q2 2018, and $2.7 million in Q1 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Savara 1.24 Bn 1.24 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2018 2.53 Mn
Sep 30, 2018 2.53 Mn
Jun 30, 2018 2.55 Mn
Jun 30, 2018 2.55 Mn
Mar 31, 2018 2.69 Mn
Mar 31, 2018 2.69 Mn
Dec 31, 2017 7.18 Mn
Dec 31, 2017 7.18 Mn
Sep 30, 2017 11.26 Mn
Sep 30, 2017 11.26 Mn
Jun 30, 2017 11.18 Mn
Jun 30, 2017 11.18 Mn
Mar 31, 2017 995,000.00
Mar 31, 2017 995,000.00
Dec 31, 2016 2.31 Mn
Dec 31, 2016 2.31 Mn
Sep 30, 2016 3.40 Mn
Sep 30, 2016 3.40 Mn
Jun 30, 2016 3.40 Mn
Jun 30, 2016 3.40 Mn